These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1990756)

  • 21. Quinidine elicits proarrhythmic changes in ventricular repolarization and refractoriness in guinea-pig.
    Osadchii OE
    Can J Physiol Pharmacol; 2013 Apr; 91(4):306-15. PubMed ID: 23627842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of spatial separation of stimulation sites on ventricular refractoriness during programmed electrical stimulation.
    Stevenson WG; Wiener I; Weiss JN
    Am Heart J; 1987 Dec; 114(6):1396-9. PubMed ID: 3687693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mexiletine and quinidine in combination in an ischemic model: supra-additive antiarrhythmic and electrophysiologic actions.
    Duff HJ; Gault NJ
    J Cardiovasc Pharmacol; 1986; 8(4):847-57. PubMed ID: 2427828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
    Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhomogeneity of ventricular refractory period in canine heart with quinidine-induced long QT interval: a comparative study on effects of heart rate, isoprenaline, and lignocaine.
    Inoue H; Toda I; Nozaki A; Matsuo H; Mashima S; Sugimoto T
    Cardiovasc Res; 1985 Oct; 19(10):623-30. PubMed ID: 4053138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ.
    Franz MR; Costard A
    Circulation; 1988 May; 77(5):1177-84. PubMed ID: 3359594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a reexcitability gap in man after treatment with type I antiarrhythmic drugs.
    Haberman RJ; Rials SJ; Stohler JL; Marinchak RA; Kowey PR
    Am Heart J; 1993 Nov; 126(5):1121-6. PubMed ID: 8237754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiologic effects of mexiletine on normal and ischemic ventricles.
    Yoon MS; Han J
    J Electrocardiol; 1982 Apr; 15(2):109-13. PubMed ID: 7069325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term rapid ventricular pacing prolongs ventricular refractoriness in patients.
    Krebs ME; Szwed JM; Shinn T; Miles WM; Zipes DP
    J Cardiovasc Electrophysiol; 1998 Oct; 9(10):1036-42. PubMed ID: 9817555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
    Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
    Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone.
    Calkins H; Sousa J; el-Atassi R; Schmaltz S; Kadish A; Morady F
    J Am Coll Cardiol; 1992 Feb; 19(2):347-52. PubMed ID: 1732363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinidine/quinine: stereospecific electrophysiologic and antiarrhythmic effects in a canine model of ventricular tachycardia.
    Sheldon RS; Rahmberg M; Duff HJ
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):818-23. PubMed ID: 1703606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of drive train stimulus intensity on ventricular refractoriness in humans.
    Langberg JJ; Calkins H; Sousa J; el-Atassi R; Morady F
    Circulation; 1991 Jul; 84(1):181-7. PubMed ID: 2060094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
    Roden DM; Iansmith DH; Woosley RL
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of bretylium tosylate on inhomogeneity of refractoriness and ventricular fibrillation threshold in canine hearts with quinidine-induced long QT interval.
    Inoue H; Toda I; Nozaki A; Matsuo H; Sugimoto T
    Cardiovasc Res; 1985 Oct; 19(10):655-60. PubMed ID: 4053141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
    Singh JB; Rasul AM; Shah A; Adams E; Flessas A; Kocot SL
    Am J Cardiol; 1984 Jan; 53(1):84-7. PubMed ID: 6362388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of sympathetic stimulation on use dependence of lidocaine, mexiletine, and quinidine in an intact canine model.
    Newman D; Herre JM; Chin M; Scheinman MM; Franz M; Katzung B
    Can J Physiol Pharmacol; 1992 Feb; 70(2):219-24. PubMed ID: 1325863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Na+ channel blockers on extrasystolic stimulation-evoked changes in ventricular conduction and repolarization.
    Osadchii OE
    J Cardiovasc Pharmacol; 2014 Mar; 63(3):240-51. PubMed ID: 24220314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.